May 27, 2017 10:59am

 

Those who have fallen, not just stocks …

 

The U.S. equity market will be closed on Monday due to Memorial Day

 

The cell therapy has been one of the worst-performing sectors …

 

Pre-open indications: 5 hits and 6 miss

 

As the leading voice of cell therapy investors; I am not always a doom and gloom reporter but a man who has been “there” with the gray hair and a readership following with real numbers to prove it!

 

I answer one question, in which company should investors commit and keep their money

 


 

RMi’s daily and continual “reads” of the goings-on of the SCG&RT sector can improve investor’s and trader’s odds - just because a stock underperforms the market doesn’t mean you have to lose money.

 

 

Henry’omics:

From the pre-open’s investor’s newsletter … “the sector will tank, but it will recover.”

  • Reiterating, “Investors will shudder, but they will adjust as they always do.”

Equities came into Friday's session riding a six-day winning streak, with the S&P and NASDAQ indexes notching record highs on Thursday.

 

May might be ending on a sour note but, June should begin with the oversold hoping to be the ... overbought!

We are also getting closer to ASCO - 6/2-7

Scepticism and uncertainty still ... UNDERCUT the upside potential ,,,

 

 

While the cell therapy sector bounced:

The cell therapy sector’s record after the last 5 days (of 43 covered companies):

·         Friday closed NEGATIVE with 28 decliners, 11 advancers and 4 flats;

·         Thursday closed NEGATIVE with 24 decliners, 17 advancers and 2 flats;

·         Wednesday closed NEGATIVE with 21 decliners, 16 advancers and 6 flats;

·         Tuesday closed POSITIVE with 15 decliners, 25 advancers and 3 flats;

·         Monday closed NEGATIVE with 21 decliners, 19 advancers and 3 flats;

·         Last Friday closed POSITIVE with 15 decliners, 26 advancers and 2 flat;

 

 

Pre-open indications: 5 hit and 6 miss

  • Applied Genetic Technologies (AGTC) closed down -$0.10 – hit;
  • AxoGen (AXGN) closed down -$0.45 – miss;
  • Bellicum Pharmaceuticals (BLCM) closed down -$0.36 – miss;
  • bluebird bio (BLUE) closed down -$1.10 – hit;
  • Capricor (CAPR) closed down -$0.01 – miss;
  • Juno Therapeutics (JUNO) closed down -$2.22 – miss;
  •  Kite Pharma (KITE) closed down -$1.80 – hit;
  • Mesoblast (MESO) closed down $0.17 – hit;
  • Organovo (ONVO) closed up +$0.09 – miss;
  • Regenxbio (RGNX) closed down -$0.65 – hit;
  • Spark Therapeutics (ONCE) closed down -$2.63 – miss;

 

 

Daily analytics:

U.S. equities closed DOWN on Thursday … with the DOW closing DOWN -0.01% (-2.67) as the NASDAQ also closed UP +0.08% (+4.94) …

… The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded near 9.8 …

· Thursday traded near 9.4 after Wednesday traded near 9.89, dipping below 10 for the first time since May 10, Tuesday closed near 10.8,Monday’s 10.9 and last Friday’s 12.2

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated a negative -0.37% at the pre-open and closed

·         Friday DOWN -0.03,

·         Thursday’s +0.07,

·         Wednesday’s +0.07% ,

·         Tuesday +0.20%,

·         Monday’s +0.30%,

·         Last Friday’s +0.48% …

… The iShares NASDAQ Biotechnology (IBB) indicate a negative -0.43% in the pre-open and closed

·         Friday DOWN -0.79 after

·         Thursday’s -0.22%,

·         Wednesday’s +0.07%,

·         Tuesday’s -0.12%,

·         Monday’s +0.68,

·         Last Friday’s -0.62

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The open was negative with an A/DL of 11/25 and 7 flats;

·         The mid-day was negative with an A/DL of 11/29 and 2 flats;

·         The close was negative with an A/DL of 11/28 and 4  flats;

 

 

The count - decliners versus gainers: look at the differences in the spreads and advance/decline lines:

·         Friday’s decliners ranged from -0.50% <BCLI> to -11.41% <ISCO> in 28 equities;

·         Thursday’s decliners ranged from -0.55% <CLLS> to -8.46% <MESO> in 24 equities;

·         Wednesday’s decliners ranged from -0.03% <OPXA> to -4.46% <CAPR> in 21 equities;

·         Tuesday’s decliners ranged from -0.24% <BCLI> to -8.54% <ISCO> in 15 equities;

·         Monday’s decliners ranged from -0.45% <BLFS> to -21.67% <BSTG> in 21 equities;

·         Last Friday’s decliners ranged from -0.17% <BSTG> to -6.78% <BLUE> in 15 equities;

Versus

·         Friday’s gainers ranged from +0.25% <BSTG> to +5.63% <VCEL> in 11 equities;

·         Thursday’s gainers ranged from +0.06% <BLUE> to +4.79% <CAPR> in 17 equities;

·         Wednesday’s gainers ranged from +0.16% <ONCE> to +8.46% <NWBO> in 16 equities;

·         Tuesday’s gainers ranged from +0.51% <OSIR> to +13.62% <BSTG> in 25 equities;

·         Monday’s gainers ranged from +0.28% <RGNX> to +12.77% <OPXA> in 19 equities;

·         Last Friday’s gainers ranged from +0.01% <HSGX> to +10.66% <QURE> in 26 equities;

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.